Pharmaceutical and biopharmaceutical laboratories increasingly need to characterize complex samples that contain APIs, ...

Could taking fish oil pills accelerate cognitive decline? That’s the alarming headline from a recently published study which ...

BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader in ...

The cloud-based agentic AI platform aims to help human researchers overcome resource constraints and complex data challenges ...

In the traditional life cycle of a building, demolition often marks an abrupt and wasteful end. Even in the case of ...

In an opinion published June 11, 2026, the U.S. Supreme Court vacated and remanded a case involving a Chapter 13 debtor who was judicially ...

The research group led by CIC biomaGUNE's Ikerbasque Research Professor Aitziber L. Cortajarena has developed an innovative ...

African leaders urged urgent reforms to remove barriers facing women traders and unlock AfCFTA’s $3.4 trillion single market ...

AI companies say we have a choice. They already made theirs.

While those timelines might not seem exciting, investors should note that Viking is due to release results from an extremely important Phase 1 maintenance clinical in the third quarter of this year.

Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.

Compounded drugs sold for cash prices don’t generate billing records that would allow regulators to track basic information, ...